Based on the preoperative assessment, intermediate-risk PTC, in comparison with low-risk PTC, was associated with age ≥ 45 years, female gender, larger tumor size, and the presence of BRAF mutation or RET/PTC rearrangements [93]. This evidence concerns the gene BRAF and neoplasm.